A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer

Lasers in Surgery and Medicine

Volumn 45, Issue 2, 2013, Pages 89-94

  Zeitouni, Nathalie C ^a   Paquette, Anne D ^a   Housel, Joseph P ^a   Shi, Yi ^b   Wilding, Gregory E ^b   Foster, Thomas H ^c   Henderson, Barbara W ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

aminolevulinic acid; basal cell carcinoma; Bowen's disease; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; LIDOCAINE; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BLEACHING; BOWEN DISEASE; CLINICAL ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; IRRADIATION; MALE; NON MELANOMA SKIN CANCER; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874505091     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22118     Document Type: Article

References (24)

1. Lee Y, Baron ED,. Photodynamic therapy: Current evidence and applications in dermatology. Semin Cutan Med Surg 2011; 30: 199-209.
2. Dirschka T, Radny P, Dominicus R, Mensing H, Bruning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klovekorn W, Reinhold U, Tanner M, Grone D, Deichmann M, Simon M, Hubinger F, Hofbauer G, Krah-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Honigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lubbert H, Szeimies RM, AK-CT002 Study Group. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: Results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol 2012; 166: 137-146.
3. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: Update. Br J Dermatol 2008; 159: 1245-1266.
4. Warren CB, Karai LJ, Vidimos A, Maytin EV,. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol 2009; 61: 1033-1043.
5. Steinbauer JM, Schreml S, Babilas P, Zeman F, Karrer S, Landthaler M, Szeimies RM,. Topical photodynamic therapy with porphyrin precursors-Assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009; 8: 1111-1116.
6. Valentine RM, Ibbotson SH, Brown CT, Wood K, Moseley H,. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy. Photochem Photobiol 2011; 87: 242-249.
7. Attili SK, Dawe R, Ibbotson S,. A review of pain experienced during topical photodynamic therapy-Our experience in Dundee. Photodiagnosis Photodyn Ther 2011; 8: 53-57.
8. von F V, Hoffmann G, Hoff-Lesch S, Abuzahra F, Renn CN, Braathen LR, Merk HF,. Photodynamic therapy of multiple actinic keratoses: Reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes. Br J Dermatol 2010; 163: 607-615.
9. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL,. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol 1993; 57 (5): 803-807.
10. Foster TH, Gibson SL, Gao L, Hilf R,. Analysis of photochemical oxygen consumption effects in photodynamic therapy. In:, Dougherty TJ, editor. Proc. SPIE Vol. 1645 " Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy ". Bellingham, WA: SPIE Press; 1992. pp. 104-114.
11. Henderson BW, Busch TM, Vaughan LA, Frawley NP, Babich D, Sosa TA, Zollo J, Dee A, Cooper M, Bellnier D, Greco W, Oseroff A,. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment depending on fluence rate. Cancer Res 2000; 60, 525-529.
12. Foster TH, Murant RS, Bryant RG, Knox RS, Gibson SL, Hilf R,. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 1991; 126: 296-303.
13. Seshadri M, Bellnier DA, Vaughan LA, Spernyak JA, Mazurchuk R, Foster TH, Henderson B,. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin Cancer Res 2008; 14: 2796-2805.
14. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR,. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008; 14: 4475-4483.
15. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, Rosén A, Larkö O, Wennberg A-M, Rosdahl I,. Photodynamic therapy of actinic keratosis at varying fluence rates: Assessment of photobleaching, pain and primary clinical outcome. Brit J Cancer 2004; 151: 1204-1212.
16. Wiegell SR, Stender IM, Na R, Wulf HC,. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003; 139: 1173-1177.
17. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH,. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 2004; 29: 560-562.
18. Radokovic-Fijan S, Blecha-Thalhammer U, Schleyer V, Szeimies RM, Zqinger T, Honignsmann H,. Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005; 152: 279-283.
19. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM,. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
20. Halldin CB, Gillstedt M, Paoli J, Wennberg AM, Gonzalez H,. Predictors of pain associated with photodynamic therapy: A retrospective study of 658 treatments. Acta Derm Venereol 2011; 91: 545-551.
21. Sitnik T, Henderson BW,. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem Photobiol 1998; 67: 462-466.
22. Sitnik TM, Hampton JA, Henderson BW,. Reduction of tumor oxygenation during and after photodynamic therapy in vivo: Effects of fluence rate. Br J Cancer 1998; 77: 1386-1394.
23. Langmack K, Mehta R, Twyman P, Norris P,. Topical photodynamic therapy at low fluence rates-Theory and practice. J Photochem Photobiol B 2001; 60: 37-43.
24. Foster TH, Gibson SL, Raubertas RF,. Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light. Br J Cancer 1996; 73: 933-936.